Canada’s Early Focus on Artificial Intelligence is Starting to Reap Commercial BenefitsUlrik Kristensen2021-11-19T16:52:15+00:00November 19th, 2021|
AI Drug Development Market Projected to Reach $5.1 Billion by 2025Ulrik Kristensen2021-11-19T16:54:14+00:00September 28th, 2021|
AI Drug Development Startups Raised $2.1B in H1 2021Ulrik Kristensen2021-11-19T16:54:52+00:00July 6th, 2021|
Royalties Challenge Risk and Reward in AI Drug DevelopmentUlrik Kristensen2021-11-19T16:56:28+00:00May 27th, 2021|
Charles River Acquired Distributed Bio – Here’s What it Means for the AI EcosystemUlrik Kristensen2021-11-19T16:58:49+00:00January 14th, 2021|
AI in Drug Development Investments Accelerated in 2020Ulrik Kristensen2021-11-19T17:00:39+00:00December 28th, 2020|
